Millennium Management’s Immunocore IMCR Stock Holding History

Millennium Management’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,000	Closed	-$471K	–	6223
2025 Q2	$471K	Buy	+15,000	New	+$466K	﹤0.01%	4952
2023 Q4	–	Sell	-60,000	Closed	-$3.11M	–	6283
2023 Q3	$3.11M	Sell	60,000 -5,000	-8%	-$296K	﹤0.01%	3171
2023 Q2	$3.9M	Hold	65,000	–	–	﹤0.01%	2891
2023 Q1	$3.21M	Buy	65,000 +7,000	+12%	+$394K	﹤0.01%	2994
2022 Q4	$3.31M	Buy	+58,000	New	+$3.26M	﹤0.01%	3132
2022 Q3	–	Sell	-34,100	Closed	-$1.27M	–	7253
2022 Q2	$1.27M	Buy	34,100 +1,700	+5%	+$55.2K	﹤0.01%	4156
2022 Q1	$969K	Buy	+32,400	New	+$818K	﹤0.01%	4558

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Millennium Management's IMCR Position: Q1 2026 in Review

Millennium Management increased its Immunocore (IMCR) stake by 36% in Q1 2026, buying an estimated $10.5M and bringing the position to 1,237,403 shares worth $37.3M. The position accounts for 0.02% of the portfolio, ranked #1055.

Millennium Management first reported a position in IMCR in Q1 2021 and has held it in 18 quarters since. The position peaked at $46M in Q3 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Millennium Management held 1,237,403 shares of Immunocore worth $37.3M as of Q1 2026.
Millennium Management bought 325,806 Immunocore shares in Q1 2026, an estimated $10.5M.
Immunocore made up 0.02% of Millennium Management's portfolio in Q1 2026, its #1055 holding.
Millennium Management first reported a position in Immunocore in Q1 2021 and has held it in 18 quarters since.
Millennium Management's Immunocore position peaked at $46M in Q3 2025.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.